Literature DB >> 7849530

In vivo and ex vivo gene transfer to the brain.

L J Fisher1, J Ray.   

Abstract

The use of gene transfer techniques to express novel proteins within different cellular populations has provided insights into the function and plasticity of the brain. Recently, this technique has been successfully used to explore physiological processes within the CNS and to intervene in neurodegenerative disease and cancer. Progress in manipulating transgene products in vivo and in achieving cell-specific targeting of genetic material offers promise for enhancing the usefulness of this technique and its therapeutic potential for treating human disorders of the CNS.

Entities:  

Mesh:

Year:  1994        PMID: 7849530     DOI: 10.1016/0959-4388(94)90017-5

Source DB:  PubMed          Journal:  Curr Opin Neurobiol        ISSN: 0959-4388            Impact factor:   6.627


  3 in total

Review 1.  Treatment of amyotrophic lateral sclerosis.

Authors:  A Eisen; M Weber
Journal:  Drugs Aging       Date:  1999-03       Impact factor: 3.923

2.  Protection of the neostriatum against excitotoxic damage by neurotrophin-producing, genetically modified neural stem cells.

Authors:  A Martínez-Serrano; A Björklund
Journal:  J Neurosci       Date:  1996-08-01       Impact factor: 6.167

3.  Particle-mediated gene transfer with transforming growth factor-beta1 cDNAs enhances wound repair in rat skin.

Authors:  S I Benn; J S Whitsitt; K N Broadley; L B Nanney; D Perkins; L He; M Patel; J R Morgan; W F Swain; J M Davidson
Journal:  J Clin Invest       Date:  1996-12-15       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.